MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study.

MLA

Richard, Edo, et al. “MRI and Cerebrospinal Fluid Biomarkers for Predicting Progression to Alzheimer’s Disease in Patients with Mild Cognitive Impairment: A Diagnostic Accuracy Study.” BMJ Open, vol. 3, no. 6, June 2013, pp. 1–8. EBSCOhost, https://doi.org/10.1136/bmjopen-2012-002541.

APA

Richard, E., Schmand, B. A., Eikelenboom, P., & Van Gool, W. A. (2013). MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer’s disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ Open, 3(6), 1–8. https://doi.org/10.1136/bmjopen-2012-002541

Chicago

Richard, Edo, Ben A. Schmand, Piet Eikelenboom, and Willem A. Van Gool. 2013. “MRI and Cerebrospinal Fluid Biomarkers for Predicting Progression to Alzheimer’s Disease in Patients with Mild Cognitive Impairment: A Diagnostic Accuracy Study.” BMJ Open 3 (6): 1–8. doi:10.1136/bmjopen-2012-002541.